AI Verdict
KMPB has stronger fundamentals based on our AI analysis.
KMTS vs KMPB Fundamental Comparison
| Metric | KMTS | KMPB |
|---|---|---|
| Revenue | $66.5M | $4.8B |
| Net Income | $-92.8M | $143.3M |
| Net Margin | -139.5% | 3.0% |
| ROE | -32.2% | 5.3% |
| ROA | -24.5% | 1.1% |
| Current Ratio | 7.32x | N/A |
| Debt/Equity | 0.15x | 0.35x |
| EPS | $-1.76 | $2.29 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
KMTS vs KMPB: Frequently Asked Questions
Is KMTS or KMPB a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), KMPB has stronger fundamentals. KMTS is rated HOLD (55% confidence) while KMPB is rated HOLD (68% confidence). This is not investment advice.
How does KMTS compare to KMPB fundamentally?
KESTRA MEDICAL TECHNOLOGIES, LTD. has ROE of -32.2% vs KEMPER Corp's 5.3%. Net margins are -139.5% vs 3.0% respectively.
Which stock pays higher dividends, KMTS or KMPB?
KMTS has a dividend yield of N/A or no dividend while KMPB has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in KMTS or KMPB for long term?
For long-term investing, consider that KMTS has HOLD rating with 55% confidence, while KMPB has HOLD rating with 68% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about KMTS vs KMPB?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For KMTS vs KMPB, the AI consensus favors KMPB based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.